Notably, Li et al. [104] observed a significant increase in GLP-1R protein expression in the duodenum and liver of NAFLD rats after eugenol administration, which may be inconsistent with prior research. Here, GLP1R is linked to metabolic dysfunction-associated steatotic liver disease.